EUCTR2009-014405-14-AT进行中（未招募）1 期
Vildagliptin in New Onset Diabetes After Transplantation (ViNODAT). A double-blind, randomized, placebo-controlled trial
Medizinische Universität Wien, Univ.Klinik Innere Medizin III, Abt.für Nephrologie u.Dialyse0 个研究点开始时间: 2009年8月11日最近更新:
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •-Newly diagnosed NODAT as defined by a pathologic OGTT (2h, 75mg glucose): glucose = 200mg/dl
- •-Age > 18 years
- •-Renal transplantation (deceased or living donor) and treatment with the standard immunosuppression of our center, consisting of tacrolimus or cyclosporine A, mycophenolate mofetil, and prednisone triple therapy without any induction
- •-Stable graft function for more than 6 months post transplant
- •-Informed consent of the patient and willingness/ability to follow the instructions of the study team
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •-Patients with prior history of type 1 or type 2 diabetes
- •-BMI > 40
- •-Pregnancy (ß-HCG in blood will be measured in all female study participants before enrollment)
- •-severe renal impairment (GFR < 30 ML/min./1.73 m2)
研究者
相似试验
已完成
2 期
Vildagliptin in New Onset Diabetes After TransplantationDiabetes MellitusNCT00980356Medical University of Vienna32
进行中（未招募）
1 期
EW-ONSET DIABETES MELLITUS AFTER RENAL TRANSPLANTATION. STUDY TO EVALUATE BELATACEPT-BASED VERSUS TACROLIMUS-BASED IMMUNOSUPPRESSIOAdult kidney transplant recipients older than 45 years old with risk of developing prediabetes states after renal transplantation (PREDAT) and diabetes mellitus after renal transplantation (NODAT)MedDRA version: 15.1Level: HLGTClassification code 10018424Term: Glucose metabolism disorders (incl diabetes mellitus)System Organ Class: 10014698 - Endocrine disordersMedDRA version: 15.1Level: LLTClassification code 10023438Term: Kidney transplantSystem Organ Class: 100000004865EUCTR2011-006162-40-ESFundació Hospital Universitari Vall d'Hebron - Institut de Recerca (VHIR)
进行中（未招募）
不适用
Effect of adding vildagliptin to start of insulin treatment in combination with metformin in patients with type 2 diabetes - Effect of adding vildagliptin to insulin treatmentpatients with type 2 diabetes, failing on maximal oral glucose-lowering drugs, starting on insulin therapy in combination with standard metfromin (2 x 850)MedDRA version: 9.1Level: LLTClassification code 10012594Term: DiabetesEUCTR2009-010967-18-NLniversity Medical Centre Utrecht40
已完成
3 期
Effect of adding vildagliptin to start of insulin treatment in patients with type 2 diabetesDiabetesNL-OMON37974Academisch Medisch Centrum40
进行中（未招募）
1 期
Empagliflozin in Post-Transplantation Diabetes MellitusEUCTR2016-001580-37-ATMedical University of Vienna16